Ubiquitylation of voltage-gated sodium channels. 2014

Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
Department of Clinical Research, University of Bern, Murtenstrasse, 35, 3010, Bern, Switzerland, Cedric.Laedermann@unil.ch.

Ion channel proteins are regulated by different types of posttranslational modifications. The focus of this review is the regulation of voltage-gated sodium channels (Navs) upon their ubiquitylation. The amiloride-sensitive epithelial sodium channel (ENaC) was the first ion channel shown to be regulated upon ubiquitylation. This modification results from the binding of ubiquitin ligase from the Nedd4 family to a protein-protein interaction domain, known as the PY motif, in the ENaC subunits. Many of the Navs have similar PY motifs, which have been demonstrated to be targets of Nedd4-dependent ubiquitylation, tagging them for internalization from the cell surface. The role of Nedd4-dependent regulation of the Nav membrane density in physiology and disease remains poorly understood. Two recent studies have provided evidence that Nedd4-2 is downregulated in dorsal root ganglion (DRG) neurons in both rat and mouse models of nerve injury-induced neuropathic pain. Using two different mouse models, one with a specific knockout of Nedd4-2 in sensory neurons and another where Nedd4-2 was overexpressed with the use of viral vectors, it was demonstrated that the neuropathy-linked neuronal hyperexcitability was the result of Nav1.7 and Nav1.8 overexpression due to Nedd4-2 downregulation. These studies provided the first in vivo evidence of the role of Nedd4-2-dependent regulation of Nav channels in a disease state. This ubiquitylation pathway may be involved in the development of symptoms and diseases linked to Nav-dependent hyperexcitability, such as pain, cardiac arrhythmias, epilepsy, migraine, and myotonias.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075702 Nedd4 Ubiquitin Protein Ligases E3 ubiquitin ligases that consist of four WW DOMAINS. They accept UBIQUITIN from E2 UBIQUITIN-CONJUGATING ENZYME as a thioester via their C-terminal HECT domains and transfer it specifically to the 63rd LYSINE residue (Lys-63) of target proteins. NEDD4 targets include many proteins and receptors with important functions for cell growth and homeostasis such as VEGFR-2; FGFR1 TYROSINE KINASE; and ERBB-4 RECEPTOR. They play a critical role in the internalization of these receptors, their degradation by LYSOSOMES, and also function as part of the ESCRT complex in VIRUS RELEASE. Nedd4 Proteins,Neuronal Precursor Cell-Expressed Developmentally Down-Regulated 4 Ligase,Neuronal Precursor Cell Expressed Developmentally Down Regulated 4 Ligase
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015640 Ion Channel Gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability. Gating, Ion Channel,Gatings, Ion Channel,Ion Channel Gatings
D044767 Ubiquitin-Protein Ligases A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes. Ubiquitin-Protein Ligase,E3 Ligase,E3 Ubiquitin Ligase,Ubiquitin Ligase E3,Ubiquitin-Protein Ligase E3,Ligase E3, Ubiquitin,Ligase E3, Ubiquitin-Protein,Ligase, E3,Ligase, E3 Ubiquitin,Ligase, Ubiquitin-Protein,Ligases, Ubiquitin-Protein,Ubiquitin Ligase, E3,Ubiquitin Protein Ligase,Ubiquitin Protein Ligase E3,Ubiquitin Protein Ligases
D053503 Epithelial Sodium Channels Sodium channels found on salt-reabsorbing EPITHELIAL CELLS that line the distal NEPHRON; the distal COLON; SALIVARY DUCTS; SWEAT GLANDS; and the LUNG. They are AMILORIDE-sensitive and play a critical role in the control of sodium balance, BLOOD VOLUME, and BLOOD PRESSURE. Epithelial Sodium Channel,Epithelial Sodium Ion Channels,ENaC (Epithelial Na+ Channel),ENaC alpha,ENaC beta,ENaC delta,ENaC gamma,Epithelial Amiloride-Sensitive Sodium Channel,Epithelial Sodium Channel, alpha Subunit,Epithelial Sodium Channel, beta Subunit,Epithelial Sodium Channel, delta Subunit,Epithelial Sodium Channel, gamma Subunit,SCNN1 alpha Subunit,SCNN1 beta Subunit,SCNN1 delta Subunit,SCNN1 gamma Subunit,Sodium Channel, Nonvoltage-gated 1 Protein, alpha Subunit,Sodium Channel, Nonvoltage-gated 1 Protein, beta Subunit,Sodium Channel, Nonvoltage-gated 1 Protein, delta Subunit,Sodium Channel, Nonvoltage-gated 1 Protein, gamma Subunit,Epithelial Amiloride Sensitive Sodium Channel,Sodium Channel, Epithelial,Sodium Channels, Epithelial,alpha Subunit, SCNN1

Related Publications

Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
June 2015, Current opinion in pharmacology,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
February 2001, Current opinion in pharmacology,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
January 2022, Frontiers in pharmacology,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
November 2000, Neuron,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
January 2004, Annual review of pharmacology and toxicology,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
April 2014, European journal of pharmacology,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
December 2004, Current drug targets. CNS and neurological disorders,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
November 2002, Epilepsia,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
January 2018, Handbook of experimental pharmacology,
Cédric J Laedermann, and Isabelle Decosterd, and Hugues Abriel
January 2008, The international journal of biochemistry & cell biology,
Copied contents to your clipboard!